Official page for Obagi Medical Center-Egypt From basic needs as hair removal to the most complicated plastic surgeries.
Address
A37, Westown HUB, Sodic West
Giza
119
Opening Hours
| Monday | 9am - 9pm |
| Tuesday | 9am - 9pm |
| Wednesday | 9am - 9pm |
| Thursday | 9am - 9pm |
| Friday | 2pm - 8pm |
| Saturday | 9am - 9pm |
| Sunday | 9am - 9pm |
Telephone
Website
Alerts
Be the first to know and let us send you an email when Obagi Medical Center - Egypt posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Practice
Send a message to Obagi Medical Center - Egypt:
Share
Our Story
Headquartered in Irvine, California, Obagi Medical Products, Inc., is a specialty pharmaceutical company that develops, markets and sells, and is the leading provider of proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispense market. The systems are designed to prevent and improve the most common and visible skin disorders in adult skin. The foundation of the company began in 1988 with the creation of the Obagi Nu-Derm ® System, developed by leading skincare experts. In 1997 the company officially began operations as Obagi Medical Products, Inc. The company has continued to grow each year, introducing multiple product lines, and expanding its sales force and corporate office. The company sells its products through a direct sales force in the United States and internationally through distribution partners in over 42 countries across North America, Central America, South America, Europe, the Middle East and Asia. Over the years, the company has developed prescription-strength skin health products and systems primarily for the dermatology, plastic surgery, and related aesthetic markets. Using its Penetrating Therapeutics™ technologies, the company’s products are designed to improve pe*******on of prescription and cosmetic agents across the skin barrier for common and visible skin conditions in adult skin including photodamage, hyperpigmentation (chloasma, melasma and freckles), senile lentigines, acne vulgaris, sun damage and rosacea. The Obagi Nu-Derm System consists of topical products, which when used as a system results in substantial improvement to many of these skin related conditions. The company continues to maintain its position a leader in skin health by having launched several successful new systems of products, including the Obagi-C Rx TM System which is the first and only prescription-strength Vitamin C and hydroquinone System; the Condition & Enhance TM System, developed to enhance the results of physician delivered surgical and non-surgical procedures; the ELASTIderm TM family of products, a one of a kind treatment developed to restore skin elasticity and collagen production, and reduce fine lines and wrinkles around the eyes and Décolletage; the CLENZIderm M.D. Acne Therapeutic Systems TM to treat and prevent acne at it’s root; and most recently the Rosaclear System developed specifically for the treatment and prevention of the signs and symptoms of rosacea. Because the Obagi ® Systems and Products contain prescription-strength formulations, the systems are only available through physicians, primarily dermatologists, plastic surgeons, medical spas and other skin care and medical specialists. Obagi Medical Products’ develops and commercializes skin health products for the dermatology, plastic surgery, and related aesthetic markets. Using its Penetrating Therapeutics technologies, Obagi Medical's products are designed to improve pe*******on of agents across the skin barrier for common and visible skin conditions in adult skin including chloasma, melasma, senile lentigines, acne vulgaris and sun damage. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, 1988; Obagi-C® Rx (the first and only prescription-strength vitamin C and hydroquinone system), 2004; Obagi® Professional-C (a line of highly stable vitamin C serums), 2005; Obagi® Condition & Enhance for use with cosmetic procedures to enhance patient outcomes and satisfaction, 2006; Obagi ELASTIderm™ eye treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, 2007; a formulation of Obagi CLENZIderm® M.D. Systems for normal to dry skin, June 2007; and Obagi ELASTIderm™ Décolletage System, January 2008, and the Rosaclear™ System for the treatment of rosacea, January 2009. Visit www.obagi.com for information. Obagi Medical Products, Inc. reserves the right to remove postings that are abusive, defamatory, obscene, fraudulent, deceptive, or misleading. Cairo : A37, Westown HUB, Sodic west, Sheikh Zayed, 6th of October
Mob. : 01201091956 - 01201090591
Alex. : Gleem 568 El Horria St.,
Tel. : (203)5851580 - (203)5851581
